Imbalanced intestinal flora as predictive factor of response to infliximab in Crohn's disease

被引：0
作者：
Zhou, Youlian [1 ]
He, Yan [1 ]
Zhang, Ting [1 ]
Wang, Zhongqiu [1 ]
Zhang, Shaoheng [1 ]
Jiang, Bo [1 ]
Chen, Ye [1 ]
机构：
[1] Nanfang Hosp, Guangzhou, Peoples R China
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2013年 / 28卷
关键词：
intestinal flora; Crohn's disease; Infliximab; predictive factor;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：805 / 805
页数：1
相关论文
共 50 条
  • [21] Correlation between intestinal flora and serum inflammatory factors in patients with Crohn's disease
    Zhang, J.
    Chen, S. -L.
    Li, L. -B.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (21) : 4913 - 4917
  • [22] Proteomics for prediction and characterization of response to infliximab in Crohn's disease:: A pilot study
    Meuwis, Marie-Alice
    Fillet, Marianne
    Lutteri, Laurence
    Maree, Raphael
    Geurts, Pierre
    de Seny, Dominique
    Malaise, Michel
    Chapelle, Jean-Paul
    Wehenkel, Louis
    Belaiche, Jacques
    Merville, Marie-Paule
    Louis, Edouard
    CLINICAL BIOCHEMISTRY, 2008, 41 (12) : 960 - 967
  • [23] Adrenomedullin: A Novel Therapy for Intractable Crohn's Disease with a Loss of Response to Infliximab
    Ashizuka, Shinya
    Kuroishi, Nobuko
    Nakashima, Koji
    Inatsu, Haruhiko
    Kita, Toshihiro
    Kitamura, Kazuo
    INTERNAL MEDICINE, 2019, 58 (11) : 1573 - 1576
  • [24] Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab
    Peeters, H.
    Louis, E.
    Baert, F.
    Dewit, O.
    Coche, J. C.
    Ferrante, M.
    Lambrecht, G.
    Colard, A.
    Van Gossum, A.
    Bossuyt, P.
    Moreels, T.
    Vander Cruyssen, B.
    Gils, A.
    De Vos, M.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2018, 81 (01) : 15 - 21
  • [25] Smoking and Early Infliximab Response in Crohn's Disease: a Meta-analysis
    Inamdar, Sumant
    Volfson, Ariy
    Rosen, Lisa
    Sunday, Suzanne
    Katz, Seymour
    Sultan, Keith
    JOURNAL OF CROHNS & COLITIS, 2015, 9 (02) : 140 - 146
  • [26] Guidelines for treatment with infliximab for Crohn's disease
    Hommes, D. W.
    Oldenburg, B.
    van Bodegraven, A. A.
    van Hogezand, R. A.
    de Jong, D. J.
    Romberg-Camps, M. J. L.
    van der Woude, J.
    Dijkstra, G.
    NETHERLANDS JOURNAL OF MEDICINE, 2006, 64 (07) : 219 - 229
  • [27] Infliximab therapy for pediatric Crohn's disease
    Veres, Gabor
    Baldassano, Robert N.
    Mamula, Petar
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (12) : 1869 - 1880
  • [28] Infliximab to treat Crohn's disease: an update
    Cottone, M.
    Criscuoli, V.
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2011, 4 : 227 - 238
  • [29] Desensitisation to infliximab in patients with Crohn's disease
    Lelong, J
    Duburque, C
    Fournier, C
    Colombel, JF
    Desreumaux, P
    Tonnel, AB
    Wallaert, B
    REVUE DES MALADIES RESPIRATOIRES, 2005, 22 (02) : 239 - 246
  • [30] Perianal Crohn's disease and infliximab therapy
    McNamara, DA
    Brophy, S
    Hyland, JMP
    SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2004, 2 (05): : 258 - 263
12345